Results 201 to 210 of about 215,861 (352)

Expression of cyclooxygenase-2 in naturally occurring bovine cutaneous fibropapillomas

open access: green, 2014
Florentina Daraban Bocaneti   +5 more
openalex   +2 more sources

Liquids as Reinforcements for Anisotropic and Tough Soft Matter Composites

open access: yesAdvanced Materials, EarlyView.
Liquid metal droplets are shaped and oriented within soft elastomers to create all‐soft matter composites with programmable mechanical anisotropy. These liquid inclusions act as fiber‐like reinforcements, enabling directional stiffness, enhanced toughness, and controlled crack steering under extreme deformation, offering new routes to resilient soft ...
Gwyneth M. Schloer   +5 more
wiley   +1 more source

Schottky Barrier Engineering in n‐Type Organic Source‐Gated Transistors Enabling High Conductance

open access: yesAdvanced Materials Technologies, EarlyView.
This study introduces a modified source electrode architecture for n‐type organic source‐gated transistors (OSGTs). By integrating Schottky and Ohmic contact regions, the design achieves a thinner depletion envelope, enhancing mobility nearly tenfold and reducing threshold voltage.
Yonghee Kim   +4 more
wiley   +1 more source

Effect of cyclooxygenase‑2 inhibition on the development of post‑traumatic stress disorder in rats

open access: hybrid, 2018
Mengyang Wang   +6 more
openalex   +2 more sources

Pre‐Encoded IFN‐I Sensitivity Exacerbates Memory T Cell Senescence in Solid Tumors

open access: yesAdvanced Science, EarlyView.
Type I interferon (IFN‐I) signaling promotes p21‐dependent cell cycle arrest in senescent tumor‐specific memory T cells, resulting in poor proliferative responses and solid tumor regression during cancer vaccination. Conversely, IFNα/β receptor blockade reinvigorates T cell proliferation to regress solid tumors and is more effective with increasing ...
Andrew Nguyen   +4 more
wiley   +1 more source

Synthesis of novel pyrazole–thiadiazole hybrid as potential potent and selective cyclooxygenase-2 (COX-2) inhibitors

open access: green, 2014
Shankar G. Alegaon   +4 more
openalex   +1 more source

Interactions of Antibody Drug Conjugate Anti‐Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy

open access: yesAdvanced Science, EarlyView.
Antibody drug conjugates deliver their cytotoxic anti‐tubulin or topoisomerase I inhibitor payloads to tumors through cancer cell receptor targeting. The released drug payloads induce cellular changes that interact with radiotherapy resulting in radiosensitization that improves cancer cell kill and stimulates anti‐tumor immune responses.
Jacqueline Lesperance   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy